Weight-Loss Drugs Cut UK Grocery Spending by £1 Billion
GLP-1 weight-loss drugs have reduced British grocery spending by over £1 billion as adoption rates rise among households.
Weight-loss drugs have reduced grocery spending in the United Kingdom by more than £1 billion, according to data from Worldpanel by Numerator. The consumer research firm found that households with at least one GLP-1 user spend an average of £389 less per year on groceries compared to non-user households.
Adoption of these medications, including Mounjaro from Eli Lilly and Company and Wegovy from Novo Nordisk, grew from 6.3% of British households in February 2026 to 8.5% by August 2026. This growth is driven by the introduction of pill formats, which now account for 11.2% of users, and increased uptake among men, who now make up 32% of the user base.
Spending patterns have shifted significantly among users, with expenditures on alcohol and crisps falling 15% more than those of non-users. Conversely, volume sales of frozen ready meals have risen 30%. Worldpanel estimates that GLP-1 usage will exceed 10% of British households by 2027.